EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets

Sabela Castañeda-Pérez, Lucía Ordieres-Ortega, Eide Diana Alves-Pereira, Antoni Riera-Mestre

Medicina Clínica · 2026

DOI: 10.1016/j.medcli.2026.107574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicina Clínica, 2026. Verfasst von Sabela Castañeda-Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, Spain; Grupo de Trabajo de Enfermedades Minoritarias, Sociedad Españ…. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Carlos III Health Institute, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Telangiectasia, Hereditary HemorrhagicHumansAngiogenesis InhibitorsAntifibrinolytic AgentsMTOR InhibitorsProto-Oncogene Proteins c-aktImmunologic FactorsMolecular Targeted TherapyTOR Serine-Threonine KinasesActivin Receptors, Type II

Stichwörter der Autor:innen

AngiogenesisAngiogénesisEpistaxisHereditary hemorrhagic telangiectasiaMalformaciones vascularesSystemic therapyTelangiectasia hemorrágica hereditariaTratamiento sistémicoVascular malformations

Substanzen

Angiogenesis InhibitorsAntifibrinolytic AgentsMTOR InhibitorsProto-Oncogene Proteins c-aktImmunologic FactorsTOR Serine-Threonine KinasesACVRL1 protein, humanActivin Receptors, Type II

Autor:innen und Institutionen

  • Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, Spain; Grupo de Trabajo de Enfermedades Minoritarias, Sociedad Española de Medicina Interna, Madrid, Spain. Electronic address: sabela.cas…
  • Grupo de Trabajo de Enfermedades Minoritarias, Sociedad Española de Medicina Interna, Madrid, Spain; Internal Medicine Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; School of Medicine, Univ…
  • Internal Medicine Department, Complexo Hospitalario Universitario de Pontevedra, Spain; Grupo de Trabajo de Enfermedades Minoritarias, Sociedad Española de Medicina Interna, Madrid, Spain.
  • Grupo de Trabajo de Enfermedades Minoritarias, Sociedad Española de Medicina Interna, Madrid, Spain; Hereditary Hemorrhagic Telangiectasia Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospit…

Förderung

  • Carlos III Health Institute
  • European Regional Development Fund

Zitieren

APA

Castañeda-Pérez, S., Ordieres-Ortega, L., Alves-Pereira, E. D., & Riera-Mestre, A. (2026). Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets. Medicina Clínica. https://doi.org/10.1016/j.medcli.2026.107574

Vancouver

Castañeda-Pérez S, Ordieres-Ortega L, Alves-Pereira ED, Riera-Mestre A. Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets. Medicina Clínica. 2026. doi:10.1016/j.medcli.2026.107574

BibTeX
@article{CastaedaPrez2026,
  author = {Castañeda-Pérez, Sabela and Ordieres-Ortega, Lucía and Alves-Pereira, Eide Diana and Riera-Mestre, Antoni},
  title = {Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets},
  journal = {Medicina Clínica},
  year = {2026},
  doi = {10.1016/j.medcli.2026.107574}
}
Kostenlos starten →